Farallon Capital Partners, L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-04-06
4:58 pm
Purchase
2023-03-2913GFOREST RD ACQUISITION CORP II
FRXB
Farallon Capital Partners, L.P.400,000
8.900%
400,000increase
(New Position)
Filing
History
2023-03-27
4:33 pm
Unchanged
2023-03-2313DEXELIXIS INC
EXEL
Farallon Capital Partners, L.P.23,466,000
7.200%
0
(Unchanged)
Filing
History
2023-03-24
1:34 pm
Purchase
2023-03-1713DCAZOO GROUP LTD
CZOO
Farallon Capital Partners, L.P.10,000
2.500%
10,000increase
(New Position)
Filing
History
2023-03-20
4:39 pm
Purchase
2023-03-0913DEXELIXIS INC
EXEL
Farallon Capital Partners, L.P.23,466,000
7.200%
23,466,000increase
(New Position)
Filing
History
2023-02-17
3:20 pm
Purchase
2023-02-0813GAVROBIO INC
AVRO
Farallon Capital Partners, L.P.259,667
7.100%
259,667increase
(New Position)
Filing
History
2023-02-14
08:27 am
Sale
2022-12-3113GBEAM THERAPEUTICS INC
BEAM
Farallon Capital Partners, L.P.3,399,921
4.800%
-151,850decrease
(-4.28%)
Filing
History
2023-02-09
4:55 pm
Sale
2022-12-3113GSHELTER ACQUISITION CORP I CL
SHQA
Farallon Capital Partners, L.P.0
0.000%
-1,650,000decrease
(Position Closed)
Filing
History
2023-02-09
4:55 pm
Purchase
2022-12-3113GSWIFTMERGE ACQUISITION CORP CL
IVCP
Farallon Capital Partners, L.P.2,205,000
9.700%
2,205,000increase
(New Position)
Filing
History
2023-02-09
4:54 pm
Purchase
2022-12-3113GPROTAGONIST THERAPEUTICS INC C
PTGX
Farallon Capital Partners, L.P.5,055,102
9.990%
5,055,102increase
(New Position)
Filing
History
2023-02-07
5:10 pm
Sale
2022-12-3113GBETTER THERAPEUTICS INC
BTTX
Farallon Capital Partners, L.P.813,556
3.400%
-536,444decrease
(-39.74%)
Filing
History
2023-02-07
5:09 pm
Sale
2022-12-3113GCLARIVATE PLC
CLVT
Farallon Capital Partners, L.P.15,177,433
2.300%
-20,148,467decrease
(-57.04%)
Filing
History
2023-02-07
5:09 pm
Purchase
2022-12-3113GAMYRIS INC
AMRSQ
Farallon Capital Partners, L.P.1,000,000
0.300%
1,000,000increase
(New Position)
Filing
History
2023-02-06
4:20 pm
Sale
2022-12-3113GSEP ACQUISITION CORP
SEPA
Farallon Capital Partners, L.P.0
0.000%
-1,732,500decrease
(Position Closed)
Filing
History
2023-02-06
09:06 am
Purchase
2022-12-3113GENANTA PHARMACEUTICALS INC
ENTA
Farallon Capital Partners, L.P.1,550,000
7.500%
1,550,000increase
(New Position)
Filing
History
2023-02-03
5:16 pm
Purchase
2022-12-3113GSAVARA INC
SVRA
Farallon Capital Partners, L.P.11,532,622
9.990%
11,532,622increase
(New Position)
Filing
History
2023-02-03
5:15 pm
Purchase
2022-12-3113GLONGBOARD PHARMACEUTICALS INC
LBPH
Farallon Capital Partners, L.P.1,417,917
9.990%
1,417,917increase
(New Position)
Filing
History
2023-02-03
5:15 pm
Sale
2022-12-3113GARAMARK
ARMK
Farallon Capital Partners, L.P.14,998,004
4.200%
-7,593,263decrease
(-33.61%)
Filing
History
2023-02-01
5:16 pm
Sale
2022-12-3113GIMAGO BIOSCIENCES INC
IMGO
Farallon Capital Partners, L.P.0
0.000%
-2,671,313decrease
(Position Closed)
Filing
History
2023-02-01
5:12 pm
Purchase
2022-12-3113GGENERATION BIO CO
GBIO
Farallon Capital Partners, L.P.124,938
2.100%
124,938increase
(New Position)
Filing
History
2023-02-01
5:09 pm
Sale
2022-12-3113GBIG SKY GROWTH PARTNERS INC
BSKYW
Farallon Capital Partners, L.P.0
0.000%
-1,550,000decrease
(Position Closed)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, Next